JP2011059102A - Skin sensitization measuring reagent - Google Patents
Skin sensitization measuring reagent Download PDFInfo
- Publication number
- JP2011059102A JP2011059102A JP2010168054A JP2010168054A JP2011059102A JP 2011059102 A JP2011059102 A JP 2011059102A JP 2010168054 A JP2010168054 A JP 2010168054A JP 2010168054 A JP2010168054 A JP 2010168054A JP 2011059102 A JP2011059102 A JP 2011059102A
- Authority
- JP
- Japan
- Prior art keywords
- organic compound
- skin sensitization
- compound
- cysteine
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010070835 Skin sensitisation Diseases 0.000 title claims abstract description 48
- 231100000370 skin sensitisation Toxicity 0.000 title claims abstract description 48
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 35
- 150000002894 organic compounds Chemical class 0.000 claims abstract description 45
- 239000000126 substance Substances 0.000 claims abstract description 31
- 238000005259 measurement Methods 0.000 claims abstract description 20
- 238000010521 absorption reaction Methods 0.000 claims abstract description 17
- 125000003396 thiol group Chemical group [H]S* 0.000 claims abstract description 9
- 238000012360 testing method Methods 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 22
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 22
- 235000018417 cysteine Nutrition 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 18
- -1 2-phenylacetyl Chemical group 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 7
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 239000012062 aqueous buffer Substances 0.000 claims description 4
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 150000001945 cysteines Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- MDBITHZZHAXREB-VIFPVBQESA-N (2r)-2-[(2-phenylacetyl)amino]-3-sulfanylpropanoic acid Chemical compound OC(=O)[C@H](CS)NC(=O)CC1=CC=CC=C1 MDBITHZZHAXREB-VIFPVBQESA-N 0.000 abstract 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 28
- 229940126062 Compound A Drugs 0.000 description 19
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 229960003180 glutathione Drugs 0.000 description 14
- 238000001514 detection method Methods 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 108010024636 Glutathione Proteins 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001944 cysteine derivatives Chemical class 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000000105 evaporative light scattering detection Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 101100348341 Caenorhabditis elegans gas-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 102100036683 Growth arrest-specific protein 1 Human genes 0.000 description 1
- 102100036685 Growth arrest-specific protein 2 Human genes 0.000 description 1
- 101001072723 Homo sapiens Growth arrest-specific protein 1 Proteins 0.000 description 1
- 101001072710 Homo sapiens Growth arrest-specific protein 2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 101100447658 Mus musculus Gas1 gene Proteins 0.000 description 1
- 101100447665 Mus musculus Gas2 gene Proteins 0.000 description 1
- 231100000493 OECD 406 (Buehler) Skin Sensitisation Toxicity 0.000 description 1
- 231100000220 OECD 429 (LLNA) Skin Sensitisation Toxicity 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本発明は、皮膚感作性測定試薬に関する。 The present invention relates to a reagent for measuring skin sensitization.
医薬、農薬、及び化粧品等の製品に含まれる化学物質はアレルギー反応を引き起こさない物質であることが肝要であり、製品開発に当っては、使用する化学物質の皮膚感作性を確認する必要がある。皮膚感作性の測定として最終的には、Maximization試験、Buehler試験、Local Lymph Node Assay等の動物実験による試験結果が必要となるが、動物実験は煩雑な作業や、多大の時間を必要とする。そのため、開発初期段階等において簡便で迅速な方法で化学物質の皮膚感作性を測定できる手段が求められていた。
煩雑な動物実験を行うことなく、被験物質の皮膚感作性を簡便かつ迅速に検定する方法として、グルタチオンを用いた皮膚感作試験が提案されている（特許文献１，２）。しかし、当該試験で用いることができる検出方法が質量分析に限られるという問題があった。
It is important that chemical substances contained in products such as pharmaceuticals, agricultural chemicals, and cosmetics are substances that do not cause allergic reactions, and it is necessary to confirm the skin sensitization of the chemical substances used in product development. is there. Eventually, the results of animal experiments such as the Maximization test, Buehler test, and Local Lymph Node Assay are required for measuring skin sensitization, but animal experiments require complicated work and a lot of time. . Therefore, there has been a demand for means capable of measuring the skin sensitization of a chemical substance by a simple and rapid method at an early stage of development.
A skin sensitization test using glutathione has been proposed as a method for easily and rapidly assaying the skin sensitization of a test substance without conducting complicated animal experiments (
本発明の目的は、化学物質の皮膚感作性を簡便かつ迅速に測定するための手段を提供することである。また、本発明の目的は、簡易な分析装置により測定が可能な皮膚感作性測定試薬を提供することである。 An object of the present invention is to provide a means for easily and rapidly measuring the skin sensitization of a chemical substance. Moreover, the objective of this invention is providing the skin sensitization measuring reagent which can be measured with a simple analyzer.
本発明者らは、簡易な分析装置の検出に用いられている検出器により検出可能な化合物を皮膚感作性測定試薬として用いることが上記課題の解決手段になりうると考え、鋭意研究の結果、本発明の完成に至った。
すなわち、本発明は以下［１］〜［１１］を提供するものである。
The present inventors believe that using a compound that can be detected by a detector used for detection of a simple analyzer as a skin sensitization measuring reagent can be a solution to the above problem, and as a result of earnest research The present invention has been completed.
That is, the present invention provides the following [1] to [11].
［１］チオール基を１個以上有する構造を有する有機化合物であって紫外、可視光又は近赤外域に吸収を有する有機化合物を測定主薬として含む皮膚感作性測定試薬。
［２］前記有機化合物が芳香族基を有するシステインの誘導体である［１］に記載の試薬。
［３］前記有機化合物がＮ−（アリールアルキルカルボニル）システインである［１］に記載の試薬。
［４］前記有機化合物がＮ−（２−フェニルアセチル）システイン又はＮ−[２−(ナフタレン−１−イル)アセチル]システインである［１］に記載の試薬。
[1] A reagent for measuring skin sensitization comprising an organic compound having a structure having at least one thiol group and having absorption in the ultraviolet, visible light, or near infrared region as a measuring agent.
[2] The reagent according to [1], wherein the organic compound is a derivative of cysteine having an aromatic group.
[3] The reagent according to [1], wherein the organic compound is N- (arylalkylcarbonyl) cysteine.
[4] The reagent according to [1], wherein the organic compound is N- (2-phenylacetyl) cysteine or N- [2- (naphthalen-1-yl) acetyl] cysteine.
［５］粉末形態で提供される［１］〜［４］のいずれか一項に記載の試薬。
［６］前記有機化合物が、有機酸塩類を含む水性緩衝液もしくは水又はこれらと有機溶媒との混合溶媒に溶解した形態で提供される［１］〜［４］のいずれか一項に記載の試薬。
［７］前記有機化合物の濃度が1mM〜500mＭである［６］に記載の試薬。
[5] The reagent according to any one of [1] to [4] provided in a powder form.
[6] The organic compound according to any one of [1] to [4], wherein the organic compound is provided in a form dissolved in an aqueous buffer solution or water containing an organic acid salt or a mixed solvent of these and an organic solvent. reagent.
[7] The reagent according to [6], wherein the concentration of the organic compound is 1 mM to 500 mM.
［８］（１）チオール基を１個以上有する構造を有する有機化合物であって紫外、可視光又は近赤外域に吸収を有する有機化合物と被験物質とを反応させること、及び
（２）前記反応による前記有機化合物の量の低下を光学的測定により検出することを含む皮膚感作性の測定方法。
［９］（１）チオール基を１個以上有する構造を有する有機化合物であって紫外、可視光又は近赤外域に吸収を有する有機化合物と被験物質とを反応させること、及び、
（１２）前記反応により生じた化合物を光学的測定により検出することを含む
皮膚感作性の測定方法。
[8] (1) reacting an organic compound having a structure having one or more thiol groups and having absorption in the ultraviolet, visible light, or near infrared region with a test substance, and (2) the reaction A method for measuring skin sensitization, which comprises detecting a decrease in the amount of the organic compound by optical measurement by optical measurement.
[9] (1) reacting an organic compound having a structure having one or more thiol groups and having absorption in the ultraviolet, visible light, or near infrared region with a test substance; and
(12) A method for measuring skin sensitization comprising detecting a compound produced by the reaction by optical measurement.
［１０］前記有機化合物がＮ−（２−フェニルアセチル）システイン又はＮ−[２−(ナフタレン−１−イル)アセチル]システインである［８］又は［９］に記載の方法。
［１１］前記工程（１）で得られる反応物をクロマトグラフィー処理することを含む［８］〜［１０］のいずれか一項に記載の方法。
[10] The method according to [8] or [9], wherein the organic compound is N- (2-phenylacetyl) cysteine or N- [2- (naphthalen-1-yl) acetyl] cysteine.
[11] The method according to any one of [8] to [10], wherein the reaction product obtained in the step (1) is chromatographed.
本発明により、汎用の簡易な分析装置により測定が可能な皮膚感作性測定試薬が提供される。本発明の試薬により化学物質の皮膚感作性を簡便かつ迅速に測定することができる。 According to the present invention, a reagent for measuring skin sensitization that can be measured by a general-purpose simple analyzer is provided. With the reagent of the present invention, the skin sensitization of a chemical substance can be measured easily and rapidly.
本明細書において、「〜」とはその前後に記載される数値を下限値及び上限値として含む意味で使用される。
本明細書において皮膚感作性の測定とは皮膚感作性の検定を含む意味であり、また、一定の基準の皮膚感作性の有無の判断、及び皮膚感作性の定量的測定を含む意味である。
In the present specification, “to” is used to mean that the numerical values described before and after it are included as a lower limit value and an upper limit value.
In the present specification, the measurement of skin sensitization is meant to include an assay of skin sensitization, and includes determination of the presence or absence of a certain standard of skin sensitization and quantitative measurement of skin sensitization. Meaning.
本発明の皮膚感作性測定試薬は、チオール基を１個以上有する構造を有する有機化合物であって紫外、可視光又は近赤外域に吸収を有する有機化合物を含む。本発明の皮膚感作性測定試薬に含まれる有機化合物はそのままの状態、又は溶液状態で、好ましくは、波長１９０〜２５００ｎｍの領域で吸収を示す化合物であり、さらに好ましくは、波長２００〜７００ｎｍの領域に吸収を示す化合物である。さらに、該波長領域に吸収極大を有する化合物が好ましい。また、本発明の皮膚感作性測定試薬に含まれる有機化合物は、好ましくは、その吸収極大のモル吸光係数（L/mol・cm）が１０以上の吸収を有する化合物であり、さらに好ましくは、モル吸光係数が１００以上の吸収を有する化合物である。特に好ましくは、波長２００〜７００ｎｍの領域に吸収極大を有し、そのモル吸光係数が１００以上の吸収を有する化合物である。 The skin sensitization measuring reagent of the present invention is an organic compound having a structure having at least one thiol group, and includes an organic compound having absorption in the ultraviolet, visible light, or near infrared region. The organic compound contained in the skin sensitization measuring reagent of the present invention is in a state as it is or in a solution state, preferably a compound exhibiting absorption in a wavelength range of 190 to 2500 nm, more preferably a wavelength of 200 to 700 nm. It is a compound that absorbs in the region. Furthermore, a compound having an absorption maximum in the wavelength region is preferable. The organic compound contained in the skin sensitization measuring reagent of the present invention is preferably a compound having an absorption maximum molar absorption coefficient (L / mol · cm) of 10 or more, more preferably A compound having an absorption with a molar extinction coefficient of 100 or more. Particularly preferred is a compound having an absorption maximum in a wavelength range of 200 to 700 nm and an absorption having a molar extinction coefficient of 100 or more.
上記の有機化合物としては例えば、システインの誘導体であって、芳香族基を有するものが挙げられる。芳香族基は、フェニル基、ナフチル基などの炭化水素系芳香族基のほか、ピリジル基、フリル基、チオフェニル基などのヘテロ元素を有するものであってもよい。上記の有機化合物として、さらに具体的には、システインのアミノ基又はカルボキシル基にアミド結合などによりベンゼン環やナフタレン環などのアリール基を結合させた化合物が挙げられる。このうち、Ｎ−（アリールアルキルカルボニル）システイン等が特に好ましい。Ｎ−（アリールアルキルカルボニル）システインにおいて、アリール基は炭素数６〜１６程度であればよい。またアルキルカルボニル基における炭素数は２〜１１程度であればよい。カルボニル基に結合するアルキル基は直鎖状、分岐鎖状、環状のいずれでもよく、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、ｓｅｃ−ブチル基、ｔｅｒｔ−ブチル基、ペンチル基、イソペンチル基、ネオペンチル基、ｔｅｒｔ−ペンチル基、ヘキシル基、へプチル基、オクチル基、ノニル基、デシル基、２−エチルヘキシル基、シクロプロピル基などを挙げることができる。上記の有機化合物としての具体例としては、Ｎ−（２−フェニルアセチル）システイン、及びＮ−[２−(ナフタレン−１−イル)アセチル]システインが挙げられる。 Examples of the organic compound include cysteine derivatives having an aromatic group. The aromatic group may have a hetero element such as a pyridyl group, a furyl group, or a thiophenyl group in addition to a hydrocarbon aromatic group such as a phenyl group or a naphthyl group. More specifically, examples of the organic compound include compounds in which an aryl group such as a benzene ring or a naphthalene ring is bonded to an amino group or a carboxyl group of cysteine through an amide bond or the like. Of these, N- (arylalkylcarbonyl) cysteine and the like are particularly preferable. In N- (arylalkylcarbonyl) cysteine, the aryl group may have about 6 to 16 carbon atoms. Moreover, the carbon number in an alkylcarbonyl group should just be about 2-11. The alkyl group bonded to the carbonyl group may be linear, branched or cyclic, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group, tert-butyl. Group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, hexyl group, heptyl group, octyl group, nonyl group, decyl group, 2-ethylhexyl group, cyclopropyl group and the like. Specific examples of the organic compound include N- (2-phenylacetyl) cysteine and N- [2- (naphthalen-1-yl) acetyl] cysteine.
上記有機化合物は公知の方法により製造することが可能であり、例えば、Ｎ−（２−フェニルアセチル）システインは以下のように合成することができる。 The organic compound can be produced by a known method. For example, N- (2-phenylacetyl) cysteine can be synthesized as follows.
水酸化ナトリウム5.1g、水126gの水溶液にＬ−シスチン7.3gを添加し、溶解する。溶液を氷水浴にて冷却し、ここへ、フェニルアセチルクロリド10.2gを滴下する。反応混合物を氷水浴下で1時間撹拌し、さらに、室温下1時間撹拌したのち、濃塩酸6mLを添加する。析出した結晶を濾取し、水で洗浄、乾燥し、Ｎ，Ｎ’−ビス（２−フェニルアセチル）シスチンを得る（9.8g）。
Ｎ，Ｎ’−ビス（２−フェニルアセチル）シスチン4.8g、亜鉛粉末2.0g、メタノール20mL、水5mLの混合物を30℃に加温し、濃硫酸3.0gを2時間かけて滴下する。反応混合物を30℃で1時間撹拌したのち、濾過により不溶物を濾別し、水60mL、塩化ナトリウム1gを加える。溶液を酢酸エチル80mLで抽出し、有機層を飽和食塩水30mLで洗浄し、硫酸マグネシウムで乾燥後、濾過、濃縮する。得られた残渣を酢酸エチル／ヘキサン＝1/1から再結晶し、乾燥後しＮ−（２−フェニルアセチル）システインを得る（3.1g）。
7.3 g of L-cystine is added to an aqueous solution of 5.1 g of sodium hydroxide and 126 g of water and dissolved. The solution is cooled in an ice-water bath, and 10.2 g of phenylacetyl chloride is added dropwise thereto. The reaction mixture is stirred for 1 hour in an ice-water bath, and further stirred for 1 hour at room temperature, and then 6 mL of concentrated hydrochloric acid is added. The precipitated crystals are collected by filtration, washed with water and dried to obtain N, N′-bis (2-phenylacetyl) cystine (9.8 g).
A mixture of 4.8 g of N, N′-bis (2-phenylacetyl) cystine, 2.0 g of zinc powder, 20 mL of methanol and 5 mL of water is heated to 30 ° C., and 3.0 g of concentrated sulfuric acid is added dropwise over 2 hours. After stirring the reaction mixture at 30 ° C. for 1 hour, insoluble materials are filtered off by filtration, and 60 mL of water and 1 g of sodium chloride are added. The solution is extracted with 80 mL of ethyl acetate, and the organic layer is washed with 30 mL of saturated brine, dried over magnesium sulfate, filtered and concentrated. The obtained residue is recrystallized from ethyl acetate / hexane = 1/1 and dried to obtain N- (2-phenylacetyl) cysteine (3.1 g).
本発明の皮膚感作性測定試薬は、上記の有機化合物のみからなるものであってもよく、測定主薬である上記の有機化合物のほかに１又は２以上の添加剤を含んでいるものであってもよい。添加剤の例としては、ｐＨ調整剤、安定化剤、等が挙げられる。また、本発明の皮膚感作性測定試薬は、上記の測定主薬及び必要に応じて上記の添加剤を、水、水性緩衝液、有機溶媒、又はこれらいずれかの混合溶媒等に溶解させたものであってもよい。
本発明の皮膚感作性測定試薬は、溶液、液体状、固体状（粉末、顆粒、凍結乾燥物、錠剤等）のいずれの形態で提供されてもよい。
The skin sensitization measuring reagent of the present invention may be composed only of the above-mentioned organic compound, and contains one or more additives in addition to the above-mentioned organic compound which is a measuring agent. May be. Examples of the additive include a pH adjuster and a stabilizer. The skin sensitization measuring reagent of the present invention is obtained by dissolving the above-mentioned measuring agent and, if necessary, the above-mentioned additives in water, an aqueous buffer solution, an organic solvent, or any mixed solvent thereof. It may be.
The reagent for measuring skin sensitization of the present invention may be provided in any form of a solution, liquid, or solid (powder, granule, lyophilized product, tablet, etc.).
本発明の皮膚感作性測定試薬は、例えば、酢酸アンモニウムなどの有機酸塩類を含む水性緩衝液もしくは水又はこれらと有機溶媒との混合溶媒に溶解した形態で、例えば約0.01μＭ〜約1Ｍ程度、通常約1mM〜約500mＭ程度の上記有機化合物の濃度として使用すればよい。被験物質は、例えば、メタノール、エタノール、アセトニトリル、アセトンなどの有機溶媒又はこれらの混合溶媒に、例えば約0.01μＭ〜約１Ｍ程度の濃度、通常約1mＭ〜約500mＭ程度の濃度となるように溶解すればよい。次いで、本発明の皮膚感作性測定試薬の測定主薬である上記有機化合物と被験物質溶液とを、上記有機化合物と被験物質のモル濃度比が例えば1：100〜20：1となるように混合し反応させればよい。反応は、上記有機化合物と被験物質とを含む溶液を、例えば約4℃〜約60℃程度の温度範囲にて保温しながら、通常約1分〜約2日間程度攪拌又は静置することによって行うことができる。 The skin sensitization measuring reagent of the present invention is, for example, in an aqueous buffer solution containing an organic acid salt such as ammonium acetate or water or a form dissolved in a mixed solvent of these with an organic solvent, for example, about 0.01 μM to about 1 M. The concentration of the organic compound is usually about 1 mM to about 500 mM. The test substance is dissolved in, for example, an organic solvent such as methanol, ethanol, acetonitrile, acetone, or a mixed solvent thereof so as to have a concentration of about 0.01 μM to about 1 M, usually about 1 mM to about 500 mM. That's fine. Next, the organic compound and the test substance solution, which are the measurement agents of the skin sensitization measuring reagent of the present invention, are mixed so that the molar concentration ratio of the organic compound and the test substance is, for example, 1: 100 to 20: 1. And react. The reaction is carried out by stirring or leaving the solution containing the organic compound and the test substance in a temperature range of about 4 ° C. to about 60 ° C. for about 1 minute to about 2 days. be able to.
該反応により、上記有機化合物と被験物質との反応性を調べることによって、被験物質の皮膚感作性を測定することができる。上記の反応性を調べるためには、皮膚感作性測定試薬溶液と被験物質溶液との混合液中における上記有機化合物の残存量および／又は上記有機化合物と被験物質との反応生成物の生成量を分析すればよい。この分析を経時的に行うことにより、上記有機化合物と被験物質との反応速度定数を求め、この値から皮膚感作性を評価することができる。 By examining the reactivity between the organic compound and the test substance, the skin sensitization property of the test substance can be measured. In order to examine the reactivity, the remaining amount of the organic compound in the mixed solution of the skin sensitization measuring reagent solution and the test substance solution and / or the amount of reaction product produced between the organic compound and the test substance Should be analyzed. By performing this analysis over time, a reaction rate constant between the organic compound and the test substance can be obtained, and skin sensitization can be evaluated from this value.
なお、残存量を分析する場合、皮膚感作性測定試薬はチオール基を有しているため、容易に酸化されて上記化合物のジスルフィド体（２量体）になることがある。そのため、上記有機化合物の残存量を定量する際には、必要に応じてジスルフィド体も含めて分析を行い、これらの総計により上記有機化合物の残存量としてもよい。 When analyzing the residual amount, since the skin sensitization measuring reagent has a thiol group, it may be easily oxidized to a disulfide form (dimer) of the above compound. Therefore, when the remaining amount of the organic compound is quantified, an analysis including the disulfide is performed as necessary, and the total amount of these may be used as the remaining amount of the organic compound.
化合物および上記反応により生成した化合物の分析方法としては、特に限定されないが、例えば、高速液体クロマトグラフィー（HPLC）、ガスクロマトグラフィー（GC）、薄層クロマトグラフィー（TLC）などにより、上記反応により生成した化合物、上記有機化合物及び被験物質を分離して分析する方法が挙げられる。上記HPLC、GC又はTLCに用いることのできるクロマトグラフ手法としては、逆相、順相、イオン交換などを挙げることができる。このようなクロマトグラフ手法に使用可能な市販のカラムやTLCとしては、例えば、LCカラムとしてはCAPCELL-PAK（資生堂製）、L-column ODS（化学品評価研究機構製）、Shodex Asahipak （昭和電工製）などを挙げることができ、TLCプレートではシリカゲル60F254（メルク社製）、Silica Gel Plate （ナカライテスク社製）などを挙げることができる。 The method for analyzing the compound and the compound produced by the above reaction is not particularly limited, but it is produced by the above reaction by, for example, high performance liquid chromatography (HPLC), gas chromatography (GC), thin layer chromatography (TLC), etc. And a method of separating and analyzing the compound, the organic compound and the test substance. Examples of chromatographic techniques that can be used for the HPLC, GC, or TLC include reverse phase, normal phase, and ion exchange. Commercially available columns and TLC that can be used for such chromatographic methods include, for example, LC columns such as CAPCELL-PAK (manufactured by Shiseido), L-column ODS (manufactured by Chemicals Evaluation and Research Organization), Shodex Asahipak (Showa Denko) Examples of TLC plates include silica gel 60F254 (Merck) and Silica Gel Plate (Nacalai Tesque).
上記反応により生成した化合物又は残存する上記有機化合物の検出方法は、特に限定されないが、例えば上記HPLC分析で利用することのできる検出器としては、紫外可視検出器、近赤外検出器、蛍光検出器、示差屈折率検出器、電気伝導度検出器、蒸発光散乱検出器などが挙げられる。紫外可視検出器としては、例えば、単波長紫外可視検出器、二波長紫外可視検出器、フォトダイオードアレイ検出器などが挙げることができる。また、このような検出法に使用可能な市販の検出器としては、紫外可視検出器、示差屈折率検出器、電気伝導度検出器の場合、島津製作所製、日立製作所製、ウォーターズ製、資生堂製などの検出器、蒸発光散乱検出器としては島津製作所製などが挙げられる。 The detection method of the compound produced by the reaction or the remaining organic compound is not particularly limited. For example, a detector that can be used in the HPLC analysis includes an ultraviolet-visible detector, a near-infrared detector, and fluorescence detection. , Differential refractive index detector, electrical conductivity detector, evaporative light scattering detector, and the like. Examples of the ultraviolet visible detector include a single wavelength ultraviolet visible detector, a dual wavelength ultraviolet visible detector, and a photodiode array detector. In addition, as a commercially available detector that can be used for such a detection method, in the case of an ultraviolet-visible detector, a differential refractive index detector, and an electrical conductivity detector, Shimadzu, Hitachi, Waters, Shiseido Examples of such detectors and evaporative light scattering detectors include those manufactured by Shimadzu Corporation.
本発明の皮膚感作性測定試薬を用いた測定方法における検出は、上記に限定されず、例えば、特開2003-14761号公報又は特開2008-139275号公報に記載の方法を参照して、分子量等に基づく、特定の質量のイオン検出により行ってもよい。 Detection in the measurement method using the skin sensitization measurement reagent of the present invention is not limited to the above, for example, refer to the method described in JP2003-14761A or JP2008-139275A, You may carry out by ion detection of the specific mass based on molecular weight etc.
また、本発明の皮膚感作性測定試薬を用いた方法においては、好ましくは光学的検出方法を用いることができる。好ましくは、上述の紫外可視検出器、近赤外検出器を用いるとよい。 In the method using the skin sensitization measuring reagent of the present invention, an optical detection method can be preferably used. Preferably, the above-described ultraviolet-visible detector and near-infrared detector are used.
以下に実施例により本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples.
[例１]
被検物質の溶液（32.5mMのアセトン溶液）1400μlと、以下に記載のＮ−（２−フェニルアセチル）システイン（以下、化合物Ａ）溶液を700μl混合し、25℃で攪拌した。この混合液を1時間後、2時間後、4時間後、24時間後にそれぞれ100μlずつサンプリングして、溶離液Aを900μl添加して混合した後に以下に記載の条件にてHPLCに供した。また、化合物Ａの標準溶液を調製後に以下に記載の条件にてHPLCに供した。得られたクロマトグラムから化合物Ａを定量して、混合液中における化合物Ａの残存量を求めた。
[Example 1]
1400 μl of the test substance solution (32.5 mM acetone solution) and 700 μl of the following N- (2-phenylacetyl) cysteine (hereinafter, compound A) solution were mixed and stirred at 25 ° C. This mixed solution was sampled 100 μl after 1 hour, 2 hours, 4 hours, and 24 hours, 900 μl of eluent A was added and mixed, and then subjected to HPLC under the conditions described below. Further, a standard solution of Compound A was prepared and subjected to HPLC under the conditions described below. Compound A was quantified from the obtained chromatogram, and the remaining amount of Compound A in the mixed solution was determined.
[化合物Ａ溶液調製]
化合物Ａ（分子量239.06）を77.7 mg秤量して、アセトン5 mlを加えて溶解し、次に窒素ガス置換した0.2M酢酸アンモニウム水溶液を加えて50 mlに定容した（6.5 mM溶液）。
[Compound A solution preparation]
77.7 mg of compound A (molecular weight 239.06) was weighed and dissolved by adding 5 ml of acetone, and then a volume of 0.2M ammonium acetate aqueous solution substituted with nitrogen gas was added to make up to 50 ml (6.5 mM solution).
[HPLC測定条件]
装置：LC-20AD（島津製作所製）
カラム：CAPCELL-PAK ODS（3.0×150 mm）
カラム温度：40℃
流速：0.4 ml/min.
検出波長：210 nm
溶離液A：蒸留水／アセトニトリル＝98／2（0.1%トリフルオロ酢酸）
溶離液B：アセトニトリル／蒸留水＝90/10（0.1%トリフルオロ酢酸）
溶出条件：A／B＝70／30
注入量：10μl
分析時間：5分間
[HPLC measurement conditions]
Equipment: LC-20AD (manufactured by Shimadzu Corporation)
Column: CAPCELL-PAK ODS (3.0 x 150 mm)
Column temperature: 40 ° C
Flow rate: 0.4 ml / min.
Detection wavelength: 210 nm
Eluent A: distilled water / acetonitrile = 98/2 (0.1% trifluoroacetic acid)
Eluent B: acetonitrile / distilled water = 90/10 (0.1% trifluoroacetic acid)
Elution condition: A / B = 70/30
Injection volume: 10μl
Analysis time: 5 minutes
[比較例１]
化合物Ａの代わりにグルタチオン（GSH）を用いて、例１と同様にGSHを定量して、混合液中におけるGSHの残存量を求めた。ただし、GSH 溶液の調製は以下のように行い、測定においてはLC/MS/MSを用いた。測定条件は、以下に示す。
LC条件
装置：LC-20AD（島津製作所製）
カラム：CAPCELL-PAK ODS（3.0×50 mm）
カラム温度：40℃
流速：0.4 ml/min.
溶離液A：蒸留水／アセトニトリル＝98／2（0.1%トリフルオロ酢酸）
溶離液B：アセトニトリル／蒸留水＝90/10（0.1%トリフルオロ酢酸）
溶出条件：A／B＝70／30
[Comparative Example 1]
Using glutathione (GSH) instead of compound A, GSH was quantified in the same manner as in Example 1 to determine the residual amount of GSH in the mixed solution. However, the GSH solution was prepared as follows, and LC / MS / MS was used for the measurement. The measurement conditions are shown below.
LC conditions Equipment: LC-20AD (manufactured by Shimadzu Corporation)
Column: CAPCELL-PAK ODS (3.0 x 50 mm)
Column temperature: 40 ° C
Flow rate: 0.4 ml / min.
Eluent A: distilled water / acetonitrile = 98/2 (0.1% trifluoroacetic acid)
Eluent B: acetonitrile / distilled water = 90/10 (0.1% trifluoroacetic acid)
Elution condition: A / B = 70/30
MS/MS条件
装置：ABI 3200QTRAP（アプライドバイオシステムズ社製）
Ionization mode:negative(-)
Source/Gas
CUR(curtain gas):20(psi)
CAD(collision gas):5
IS(ionspray voltage):-4000(volts)
GAS1(ion source gas1):70
GAS2(ion source gas2):80
Compound
DP((declustering potential):-40(volts)
EP(entrance potential):-4.5(volts)
CE(collision energy):-26(volts)
CXP(collision cell exit potential):0(volts)
検出：m/z 306.1 → m/z 143.1 (transition)
MS / MS conditions Equipment: ABI 3200QTRAP (Applied Biosystems)
Ionization mode: negative (-)
Source / Gas
CUR (curtain gas): 20 (psi)
CAD (collision gas): 5
IS (ionspray voltage): -4000 (volts)
GAS1 (ion source gas1): 70
GAS2 (ion source gas2): 80
Compound
DP ((declustering potential):-40 (volts)
EP (entrance potential):-4.5 (volts)
CE (collision energy): -26 (volts)
CXP (collision cell exit potential): 0 (volts)
Detection: m / z 306.1 → m / z 143.1 (transition)
[GSH溶液調製]
グルタチオン（GSH 分子量307.32）を100 mg秤量して、窒素ガス置換した0.2M酢酸アンモニウム水溶液を加えて50 mlに定容した（6.5 mM溶液）。
[GSH solution preparation]
100 mg of glutathione (GSH molecular weight 307.32) was weighed, and 0.2 M ammonium acetate aqueous solution substituted with nitrogen gas was added to adjust the volume to 50 ml (6.5 mM solution).
[測定結果]
被験化合物として以下の6化合物を使用して、上記例１および比較例１に従った皮膚感作性の測定を行った。その結果を表１及び図１に示す。
（被験化合物）
BQ：ｐ−ベンゾキノン（皮膚感作性：極めて強度）（分子量108.10）
DNCB：1−クロロ−２，４−ジニトロベンゼン（皮膚感作性：極めて強度）（分子量202.55）
CA: 桂皮アルデヒド（皮膚感作性：中程度）（分子量132.16）
CTR: シトラール（皮膚感作性：中程度）（分子量：152.26）
EDM: エチレングリコールジメタクリレート（皮膚感作性：弱）（分子量198.24）
HPM: ２−ヒドロキシプロピルメタクリレート（皮膚感作性：なし）（分子量144.19）
[Measurement result]
Using the following 6 compounds as test compounds, skin sensitization was measured according to Example 1 and Comparative Example 1. The results are shown in Table 1 and FIG.
(Test compound)
BQ: p-benzoquinone (skin sensitization: extremely strong) (molecular weight 108.10)
DNCB: 1-chloro-2,4-dinitrobenzene (skin sensitization: extremely strong) (molecular weight 202.55)
CA: cinnamaldehyde (skin sensitization: moderate) (molecular weight 132.16)
CTR: Citral (Skin sensitization: Moderate) (Molecular weight: 152.26)
EDM: Ethylene glycol dimethacrylate (skin sensitization: weak) (molecular weight 198.24)
HPM: 2-hydroxypropyl methacrylate (skin sensitization: none) (molecular weight 144.19)
上記結果において、皮膚感作性は各時間におけるGSH又は化合物Ａの残存率(%)が低いほど高いと判断される。
上記の結果、GSHを用いた例と化合物Ａを用いた例で得られる結果は、類似していることがわかる。
In the above results, the skin sensitization is judged to be higher as the residual rate (%) of GSH or Compound A at each time is lower.
From the above results, it can be seen that the results obtained in the example using GSH and the example using Compound A are similar.
[例２]
上記と同様に調製した被検物質の溶液と、化合物Ａの溶液を用い、例１と同様に化合物Ａを定量して、混合液中における化合物Ａの残存量を求めた（「被検物質／化合物Ａ」＝１０）。ただし、測定方法は例１と同様とした。
反応した化合物Ａの自然対数値を縦軸、反応時間を横軸にしてグラフ作成し、作成したグラフの傾きから反応速度定数を算出した。
さらに、被検物質の溶液の濃度を６５mM、１３０mMに変更した例（それぞれ「被検物質／化合物Ａ」が２０および４０）で同様に、反応速度定数を算出した。さらに、反応速度定数を縦軸、化合物Aと感作性物質との比率を横軸にしてグラフを作成した。結果を図２に示す。
[Example 2]
Using a solution of the test substance prepared in the same manner as above and a solution of compound A, compound A was quantified in the same manner as in Example 1 to determine the remaining amount of compound A in the mixture (“test substance / Compound A "= 10). However, the measurement method was the same as in Example 1.
A graph was created with the natural logarithm of the reacted compound A as the vertical axis and the reaction time as the horizontal axis, and the reaction rate constant was calculated from the slope of the created graph.
Furthermore, reaction rate constants were calculated in the same manner in examples in which the concentration of the test substance solution was changed to 65 mM and 130 mM (“test substance / compound A” was 20 and 40, respectively). Further, a graph was prepared with the reaction rate constant on the vertical axis and the ratio of compound A and sensitizer on the horizontal axis. The results are shown in FIG.
[例３]
化合物Ａの代わりにＮ−[２−(ナフタレン−１−イル)アセチル]システイン（以下、化合物Ｂ）を用い、例２と同様の手順で測定および計算を行いグラフを作成した。なお、化合物Bの測定方法は、化合物Aの測定条件に準じたが、測定波長は２８１nmとした。結果を図３に示す。
[Example 3]
Using N- [2- (naphthalen-1-yl) acetyl] cysteine (hereinafter referred to as Compound B) instead of Compound A, measurement and calculation were performed in the same procedure as in Example 2 to prepare a graph. The measurement method for Compound B was in accordance with the measurement conditions for Compound A, but the measurement wavelength was 281 nm. The results are shown in FIG.
[比較例２]
化合物Ａの代わりにGSHを用い、例２と同様の手順で測定および計算を行いグラフを作成した。ただし、測定においては波長210 nmでの検出の代わりにLC/MS/MSを用いた。LC/MS/MSの条件は比較例１と同様である。結果を図４に示す。
[Comparative Example 2]
Using GSH instead of Compound A, measurement and calculation were performed in the same procedure as in Example 2 to prepare a graph. However, in the measurement, LC / MS / MS was used instead of detection at a wavelength of 210 nm. LC / MS / MS conditions are the same as in Comparative Example 1. The results are shown in FIG.
Claims (11)
（２）前記反応による前記有機化合物の量の低下を光学的測定により検出することを含む
皮膚感作性の測定方法。 (1) reacting an organic compound having a structure having at least one thiol group and having absorption in the ultraviolet, visible light, or near infrared region with a test substance; and (2) the organic by the reaction. A method for measuring skin sensitization comprising detecting a decrease in the amount of a compound by optical measurement.
（１２）前記反応により生じた化合物を光学的測定により検出することを含む
皮膚感作性の測定方法。 (1) reacting a test substance with an organic compound having a structure having one or more thiol groups and having absorption in the ultraviolet, visible light, or near infrared region; and
(12) A method for measuring skin sensitization comprising detecting a compound produced by the reaction by optical measurement.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010168054A JP5466105B2 (en) | 2009-08-13 | 2010-07-27 | Reagent for skin sensitization |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009187784 | 2009-08-13 | ||
| JP2009187784 | 2009-08-13 | ||
| JP2010168054A JP5466105B2 (en) | 2009-08-13 | 2010-07-27 | Reagent for skin sensitization |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011059102A true JP2011059102A (en) | 2011-03-24 |
| JP5466105B2 JP5466105B2 (en) | 2014-04-09 |
Family
ID=43946880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010168054A Active JP5466105B2 (en) | 2009-08-13 | 2010-07-27 | Reagent for skin sensitization |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5466105B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014037995A (en) * | 2012-08-13 | 2014-02-27 | Fujifilm Corp | Skin sensitization measuring reagent |
| WO2020045621A1 (en) | 2018-08-31 | 2020-03-05 | 富士フイルム株式会社 | Skin sensitization measuring method and skin sensitization measuring reagent |
| WO2020129509A1 (en) | 2018-12-21 | 2020-06-25 | 富士フイルム株式会社 | Phototoxicity or photoallergy measurement method and reagent for use in said measurement method |
| JPWO2021060477A1 (en) * | 2019-09-26 | 2021-04-01 | ||
| JPWO2021193700A1 (en) * | 2020-03-25 | 2021-09-30 | ||
| WO2022085762A1 (en) | 2020-10-22 | 2022-04-28 | 富士フイルム株式会社 | Reagent for measuring skin sensitization, compound, and method for measuring skin sensitization |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003014761A (en) * | 2001-06-29 | 2003-01-15 | Sumitomo Chem Co Ltd | Skin sensitivity test method |
| JP2007183208A (en) * | 2006-01-10 | 2007-07-19 | Shiseido Co Ltd | In vitro evaluation method of sensitive material |
-
2010
- 2010-07-27 JP JP2010168054A patent/JP5466105B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003014761A (en) * | 2001-06-29 | 2003-01-15 | Sumitomo Chem Co Ltd | Skin sensitivity test method |
| JP2007183208A (en) * | 2006-01-10 | 2007-07-19 | Shiseido Co Ltd | In vitro evaluation method of sensitive material |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014037995A (en) * | 2012-08-13 | 2014-02-27 | Fujifilm Corp | Skin sensitization measuring reagent |
| WO2020045621A1 (en) | 2018-08-31 | 2020-03-05 | 富士フイルム株式会社 | Skin sensitization measuring method and skin sensitization measuring reagent |
| JPWO2020045621A1 (en) * | 2018-08-31 | 2021-09-16 | 富士フイルム株式会社 | Skin sensitization measurement method and skin sensitization measurement reagent |
| JP7104793B2 (en) | 2018-08-31 | 2022-07-21 | 富士フイルム株式会社 | Skin sensitization measurement method and skin sensitization measurement reagent |
| WO2020129509A1 (en) | 2018-12-21 | 2020-06-25 | 富士フイルム株式会社 | Phototoxicity or photoallergy measurement method and reagent for use in said measurement method |
| JPWO2020129509A1 (en) * | 2018-12-21 | 2021-11-04 | 富士フイルム株式会社 | Methods for measuring phototoxicity or photoallergy and reagents for use in the above measuring methods |
| JPWO2021060477A1 (en) * | 2019-09-26 | 2021-04-01 | ||
| WO2021060477A1 (en) | 2019-09-26 | 2021-04-01 | 富士フイルム株式会社 | Reagent for measuring skin sensitization, method for measuring skin sensitization, and compound |
| JP7273173B2 (en) | 2019-09-26 | 2023-05-12 | 富士フイルム株式会社 | Reagent for measuring skin sensitization, method for measuring skin sensitization, and compound |
| JPWO2021193700A1 (en) * | 2020-03-25 | 2021-09-30 | ||
| WO2021193700A1 (en) | 2020-03-25 | 2021-09-30 | 富士フイルム株式会社 | Method for measuring respiratory sensitization and respiratory sensitization measuring reagent |
| WO2022085762A1 (en) | 2020-10-22 | 2022-04-28 | 富士フイルム株式会社 | Reagent for measuring skin sensitization, compound, and method for measuring skin sensitization |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5466105B2 (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5466105B2 (en) | Reagent for skin sensitization | |
| Xiong et al. | Cyanine-based NIR fluorescent probe for monitoring H2S and imaging in living cells and in vivo | |
| Zhao et al. | A viscosity sensitive azide-pyridine BODIPY-based fluorescent dye for imaging of hydrogen sulfide in living cells | |
| Corradini et al. | Fluorescent chemosensor for organic guests and copper (II) ion based on dansyldiethylenetriamine-modified β-cyclodextrin | |
| US8143069B2 (en) | Fluorescent probe and method of measuring hypochlorite ion | |
| Li et al. | An ICT-based fluorescent switch-on probe for hydrogen sulfide in living cells | |
| Zhang et al. | An iminocoumarin benzothiazole-based fluorescent probe for imaging hydrogen sulfide in living cells | |
| JP5997543B2 (en) | Reagent for skin sensitization | |
| Krzyminski et al. | Chemiluminogenic features of 10-methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonates alkyl substituted at the benzene ring in aqueous media | |
| Wang et al. | A fluorescent probe with an aggregation-enhanced emission feature for real-time monitoring of low carbon dioxide levels | |
| CN109836394B (en) | Near-infrared fluorescent probe for identifying hydrogen sulfide and preparation method and application thereof | |
| EP4234537A1 (en) | Reagent for measuring skin sensitization, compound, and method for measuring skin sensitization | |
| Yan et al. | Phenothiazine-based fluorescent probe for fluoride ions and its applications in rapid detection of endemic disease | |
| Yu et al. | A diethylamino pyridine formyl Schiff base as selective recognition chemosensor for biological thiols | |
| CN106831692B (en) | A kind of quick high-selectivity hypersensitive nickel ion colorimetric fluorescence probe and preparation method thereof | |
| CN105524055A (en) | Preparation and application of fluorescent probe capable of being used for distinguishing cysteine/homocysteine and glutathione | |
| Wang et al. | Endoplasmic reticulum-targeted fluorogenic probe based on pyrimidine derivative for visualizing exogenous/endogenous H2S in living cells | |
| Wang et al. | A near-infrared squaraine dye for cascade recognition of copper ion and biological phosphate and its application in IMPLICATION logic gate | |
| Zhang et al. | Highly sensitive and selective detection of biothiols by a new low dose colorimetric and fluorescent probe | |
| Zhou et al. | A β-d-galactose-guided fluorescent probe for selectively bioimaging endogenous formaldehyde in living HepG-2 cells | |
| Liu et al. | Fluorescence detection of glutathione and oxidized glutathione in blood with a NIR-excitable cyanine probe | |
| Pavankumar et al. | New simple molecular fluorescent probes for rapid and highly selective sensing of hydrazine by aggregate-induced emission | |
| Gu et al. | A new highly selective fluorescence probe for the imaging of endogenous formaldehyde in living cells | |
| Ren et al. | Ultrafast 2, 7-Naphthyridine-Based fluorescent probe for detection of thiophenol with a remarkable Stokes shift and its application In vitro and in vivo | |
| Yang et al. | A highly sensitive fluorescence probe for thiophenol in living cells via a substitution-cyclization strategy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130125 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131114 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131126 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131218 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140114 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140123 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5466105 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |